Immunogenicity of RSV F DNA Vaccine in BALB/c Mice
Respiratory syncytial virus (RSV) causes severe acute lower respiratory tract disease leading to numerous hospitalizations and deaths among the infant and elderly populations worldwide. There is no vaccine or a less effective drug available against RSV infections. Natural RSV infection stimulates th...
Saved in:
Main Authors: | Erdal Eroglu, Ankur Singh, Swapnil Bawage, Pooja M. Tiwari, Komal Vig, Shreekumar R. Pillai, Vida A. Dennis, Shree R. Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Advances in Virology |
Online Access: | http://dx.doi.org/10.1155/2016/7971847 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Flavonoid Naringenin: A Potential Immunomodulator for Chlamydia trachomatis Inflammation
by: Abebayehu N. Yilma, et al.
Published: (2013-01-01) -
SPERMATOGENESIS INDICES IN INBRED STRAINS DD/HE AND BALB/CLAC AND THEIR F1 RECIPROCAL CROSSES
by: M. A. Kleshchev, et al.
Published: (2014-12-01) -
Economic and Clinical Benefits of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of RSV in Infants: A Cost-Effectiveness Analysis for Mexico
by: José Luis Huerta, et al.
Published: (2025-01-01) -
The Anti-Inflammatory Cytokine, Interleukin-10, Inhibits Inflammatory Mediators in Human Epithelial Cells and Mouse Macrophages Exposed to Live and UV-Inactivated Chlamydia trachomatis
by: Abebayehu N. Yilma, et al.
Published: (2012-01-01) -
The Use of Albuterol in Young Infants Hospitalized with Acute RSV Bronchiolitis
by: Michael T. Del Vecchio, et al.
Published: (2012-01-01)